Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Wandel

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Sexually Transmitted Infections|July 25, 2008
Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies, Simon Wandel, Matthias Egger, et al.
Circulation|November 4, 2024
Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-AnalysisHarpreet S Bhatia, Simon Wandel, Peter Willeit, et al.
Patterns (New York, N.Y.)|August 25, 2021
Predicting drug approvals: The Novartis data science and artificial intelligence challengeKien Wei Siah, Nicholas W Kelley, Steffen Ballerstedt, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound studyParham Eshtehardi, Stéphane Cook, Simon Wandel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 8, 2011
How valuable are multiple treatment comparison methods in evidence-based health-care evaluation?Nicola J Cooper, Jaime Peters, Monica C W Lai, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Sirolimus versus paclitaxel coronary stents in clinical practiceNiklas Millauer, Peter Jüni, Alexandra Hofmann, et al.
European Heart Journal|February 15, 2008
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patientsMichael Billinger, Jonas Beutler, Keywan R Taghetchian, et al.
Circulation|June 8, 2011
Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trialLorenz Räber, Lea Wohlwend, Mathias Wigger, et al.
Arthritis and Rheumatism|October 31, 2007
Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trialPeter Jüni, Stephan Reichenbach, Sven Trelle, et al.
Therapeutic Innovation & Regulatory Science|September 3, 2022
Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric ExtrapolationThomas R Fleming, Christine E Garnett, Laurie S Conklin, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Sexually Transmitted Infections|July 25, 2008
Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies, Simon Wandel, Matthias Egger, et al.
Circulation|November 4, 2024
Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-AnalysisHarpreet S Bhatia, Simon Wandel, Peter Willeit, et al.
Patterns (New York, N.Y.)|August 25, 2021
Predicting drug approvals: The Novartis data science and artificial intelligence challengeKien Wei Siah, Nicholas W Kelley, Steffen Ballerstedt, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound studyParham Eshtehardi, Stéphane Cook, Simon Wandel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 8, 2011
How valuable are multiple treatment comparison methods in evidence-based health-care evaluation?Nicola J Cooper, Jaime Peters, Monica C W Lai, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Sirolimus versus paclitaxel coronary stents in clinical practiceNiklas Millauer, Peter Jüni, Alexandra Hofmann, et al.
European Heart Journal|February 15, 2008
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patientsMichael Billinger, Jonas Beutler, Keywan R Taghetchian, et al.
Circulation|June 8, 2011
Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trialLorenz Räber, Lea Wohlwend, Mathias Wigger, et al.
Arthritis and Rheumatism|October 31, 2007
Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trialPeter Jüni, Stephan Reichenbach, Sven Trelle, et al.
Therapeutic Innovation & Regulatory Science|September 3, 2022
Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric ExtrapolationThomas R Fleming, Christine E Garnett, Laurie S Conklin, et al.
Pageof 4